These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
410 related items for PubMed ID: 11721174
1. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. Poon TC, Chan AT, Zee B, Ho SK, Mok TS, Leung TW, Johnson PJ. Oncology; 2001; 61(4):275-83. PubMed ID: 11721174 [Abstract] [Full Text] [Related]
2. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development]. Kim KA, Lee JS, Jung ES, Kim JY, Bae WK, Kim NH, Moon YS. Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920 [Abstract] [Full Text] [Related]
3. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R, Wang B, Ding H, Shen H, Li Y, Chen X. Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [Abstract] [Full Text] [Related]
4. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma. Mao L, Wang Y, Wang D, Han G, Fu S, Wang J. PLoS One; 2017 Jan; 12(9):e0183880. PubMed ID: 28902891 [Abstract] [Full Text] [Related]
5. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G. Anticancer Res; 2003 Jan; 23(2C):1747-53. PubMed ID: 12820452 [Abstract] [Full Text] [Related]
6. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W. PLoS One; 2015 Jan; 10(5):e0127518. PubMed ID: 25996938 [Abstract] [Full Text] [Related]
7. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM. Hepatogastroenterology; 2009 Jan; 56(94-95):1417-24. PubMed ID: 19950803 [Abstract] [Full Text] [Related]
8. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis. Wang Y, Yang H, Xu H, Lu X, Sang X, Zhong S, Huang J, Mao Y. J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824 [Abstract] [Full Text] [Related]
9. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma. Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L. J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443 [Abstract] [Full Text] [Related]
10. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis. Worland T, Harrison B, Delmenico L, Dowling D. J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172 [Abstract] [Full Text] [Related]
11. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]. Jia HL, Xing XJ, Ye QH, Qin LX. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617 [Abstract] [Full Text] [Related]
12. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers. Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P. J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164 [Abstract] [Full Text] [Related]
13. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea. Ahn DG, Kim HJ, Kang H, Lee HW, Bae SH, Lee JH, Paik YH, Lee JS. Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857 [Abstract] [Full Text] [Related]
14. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis. Gopal P, Yopp AC, Waljee AK, Chiang J, Nehra M, Kandunoori P, Singal AG. Clin Gastroenterol Hepatol; 2014 May; 12(5):870-7. PubMed ID: 24095974 [Abstract] [Full Text] [Related]
15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [Abstract] [Full Text] [Related]
16. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis. Wang N, Cao Y, Song W, He K, Li T, Wang J, Xu B, Si HY, Hu CJ, Li AL. J Gastroenterol Hepatol; 2014 Oct; 29(7):1544-50. PubMed ID: 24612022 [Abstract] [Full Text] [Related]
17. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma. Best J, Bilgi H, Heider D, Schotten C, Manka P, Bedreli S, Gorray M, Ertle J, van Grunsven LA, Dechêne A. Z Gastroenterol; 2016 Dec; 54(12):1296-1305. PubMed ID: 27936479 [Abstract] [Full Text] [Related]
18. Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time. Lee E, Edward S, Singal AG, Lavieri MS, Volk M. Clin Gastroenterol Hepatol; 2013 Apr; 11(4):437-40. PubMed ID: 23247324 [Abstract] [Full Text] [Related]
19. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation. Siripongsakun S, Wei SH, Lin S, Chen J, Raman SS, Sayre J, Tong MJ, Lu DS. J Gastroenterol Hepatol; 2014 Jan; 29(1):157-64. PubMed ID: 24354994 [Abstract] [Full Text] [Related]
20. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, Saishoji A, Kure T, Ohno K, Toyokura E, Imanaka D, Moriuchi A, Uto H, Oketani M, Hashiguchi T, Tsubouchi H. Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]